相关实验视频

Updated: May 6, 2026

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

15.8K

加拿大卫生部有条件批准的瘤产品的治疗价值:一个横截面研究

Joel Lexchin1,2

  • 1School of Health Policy and Management, York University, Toronto, ON, Canada.

JRSM open
|March 24, 2025
PubMed
概括

很少有条件批准的新瘤药物提供重大治疗改善. 这项研究评估了加拿大卫生部批准的新型癌症药物,发现与现有治疗方法相比,药物具有有限的显著益处.

关键词:
加拿大卫生部加拿大卫生部有条件的批准批准班级中的第一名.瘤学药物 瘤学药物孤儿药物是一种孤儿药物.它具有治疗价值,具有治疗价值.

更多相关视频

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.0K
Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

7.8K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K